KPI Global Infrastructure Ltd. shares migrate to BSE mainboard platform, listed on NSE

Surat (Gujarat) [India], July 28: The month of July ushered in a huge development for KPI Global Infrastructure Limited, the solar power company of Surat-based KP Group, and its investors.

On July 23, KPI Global Infrastructure Ltd. received an approval letter from BSE Limited for the migration of its equity shares from the BSE SME platform to the main board of BSE. While on the same day, the company also received an approval letter from the National Stock Exchange of India Limited (NSE) for the listing of its shares on the NSE main board platform. The equity shares of KPI Global Infrastructure started trading on the two platforms on July 27.

Speaking with reporters, KPI Global Infrastructure Ltd.’s founder cum promoter Mr. Faruk Patel expressed gratitude towards BSE & NSE and said that the trading of equity shares on both the exchanges would lead to greater visibility for the company and will allow the company to deliver higher value to all the stakeholders.

Sharing details about the projects undertaken by the company, Mr. Patel said, “We have executed more than 60 MW of solar power projects under the Captive Power Producer (CPP) and Independent Power Producer (IPP) models so far, and 40 MW projects are in the advanced stage of completion. We aim to touch 1,000 MW of solar projects by 2025 and are confident of delivering high-quality projects in the future too. We also take this opportunity to express our gratitude towards the shareholders for their faith in us.”

It is worth mentioning that KPI Global Infrastructure Ltd came out with its IPO on January 22, 2019. The company raised Rs. 39.94 crore by issuing 49,92,000 equity shares. The IPO was oversubscribed by more than 11 times.



49 thoughts on “KPI Global Infrastructure Ltd. shares migrate to BSE mainboard platform, listed on NSE

  1. I am glad to have been a friend propecia regrowth 6C The ROC curves obtained when using the SL based neural network predictors to predict gene essentiality in BT549, and testing the predictions according to the refined set of genes that were found as essential across all three BT549 screens

  2. Patients who are prescribed Lipitor should be aware that it may interact with certain medications used to treat urinary tract infections, and should inform their healthcare provider if they are taking any of these medications. atorvastatin 20mg spc.

  3. synthroid 50 pill
    In summary, Synthroid is a safe and effective treatment option for hypothyroidism and certain types of thyroid cancer. Patients should take this medication as directed by the doctor, and should report any changes in symptoms or side effects to the doctor. With proper use, Synthroid can help patients manage their thyroid condition and improve their overall health and wellbeing.

  4. levothyroxine 100 mcg
    Other potential side effects of Synthroid may include headaches, nervousness, and weight changes. In some cases, these side effects may resolve on their own over time, but in other cases, the doctor may need to adjust the dose of the medication or prescribe additional medications to manage these side effects.

  5. The major side effects observed in this study hypotension, cough, and elevated serum potassium levels are similar to those observed in the SOLVD Treatment Trial and other trials of angiotensin converting enzyme inhibitors in similar patients tadalafil cialis Paclitaxel Injections

Leave a Reply

Your email address will not be published.